Other News To Note
Friday, December 17, 2010
Orexo AB, of Uppsala, Sweden, said partner Boehringer Ingelheim GmbH, of Ingelheim, Germany, selected a development candidate from the firms' 2005 collaboration focused on pain and inflammatory diseases. That selection triggered a €6.5 million (US8.6 million) milestone payment to Orexo.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.